trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Leukemia, Myelomonocytic, Acute D015479 6 associated lipids
Uveal Neoplasms D014604 3 associated lipids
Opioid-Related Disorders D009293 5 associated lipids
Neuroendocrine Tumors D018358 4 associated lipids
Sciatic Neuropathy D020426 13 associated lipids
Adenocarcinoma, Papillary D000231 2 associated lipids
von Hippel-Lindau Disease D006623 1 associated lipids
Cystadenocarcinoma, Mucinous D018282 1 associated lipids
Cystadenocarcinoma, Serous D018284 2 associated lipids
Thyroid Hormone Resistance Syndrome D018382 1 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Herman D et al. Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia. 2006 Nat. Chem. Biol. pmid:16921367
Bradner JE et al. Chemical phylogenetics of histone deacetylases. 2010 Nat. Chem. Biol. pmid:20139990
Kaida D et al. Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA. 2007 Nat. Chem. Biol. pmid:17643111
Kotake Y et al. Splicing factor SF3b as a target of the antitumor natural product pladienolide. 2007 Nat. Chem. Biol. pmid:17643112
Janowski BA et al. Activating gene expression in mammalian cells with promoter-targeted duplex RNAs. 2007 Nat. Chem. Biol. pmid:17259978
Bracha AL et al. Carbon metabolism-mediated myogenic differentiation. 2010 Nat. Chem. Biol. pmid:20081855
Hutt DM et al. Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis. 2010 Nat. Chem. Biol. pmid:19966789
Miyake Y et al. Structural insights into HDAC6 tubulin deacetylation and its selective inhibition. 2016 Nat. Chem. Biol. pmid:27454931
Yeh JR et al. Discovering chemical modifiers of oncogene-regulated hematopoietic differentiation. 2009 Nat. Chem. Biol. pmid:19172146
Guilluy C et al. Isolated nuclei adapt to force and reveal a mechanotransduction pathway in the nucleus. 2014 Nat. Cell Biol. pmid:24609268
Taddei A et al. Reversible disruption of pericentric heterochromatin and centromere function by inhibiting deacetylases. 2001 Nat. Cell Biol. pmid:11175742
Seo H et al. Rapid generation of specific antibodies by enhanced homologous recombination. 2005 Nat. Biotechnol. pmid:15924134
Seo H et al. An ex vivo method for rapid generation of monoclonal antibodies (ADLib system). 2006 Nat Protoc pmid:17406441
Shi Q et al. [Inhibitory effect of trichostatin A on HepG2 cell proliferation and the mechanisms]. 2014 Nan Fang Yi Ke Da Xue Xue Bao pmid:25057056
Xu M et al. Histone deacetylase inhibitors induce human renal cell carcinoma cell apoptosis through p-JNK activation. 2013 Nan Fang Yi Ke Da Xue Xue Bao pmid:24144737
Peng L et al. [Tricostantin A inhibits self-renewal of breast cancer stem cells in vitro]. 2013 Nan Fang Yi Ke Da Xue Xue Bao pmid:24144739
WEI Q et al. [Trichostatin A inhibits the activation of CD(4)(+) T cells by suppressing CD(28) expression in mice]. 2011 Nan Fang Yi Ke Da Xue Xue Bao pmid:21421475
Wei Q et al. [Effect of trichostatin A on proliferation and interleukin-2 expression of mouse T cells in mixed lymphocyte culture]. 2008 Nan Fang Yi Ke Da Xue Xue Bao pmid:18359716
Lu Y and Zhang K Cellular Reprogramming in the Retina - Seeing the Light. 2018 N. Engl. J. Med. pmid:29539280
Meschini R et al. Role of chromatin structure modulation by the histone deacetylase inhibitor trichostatin A on the radio-sensitivity of ataxia telangiectasia. 2015 Mutat. Res. pmid:25942615
Sutherland JE et al. The histone deacetylase inhibitor trichostatin A reduces nickel-induced gene silencing in yeast and mammalian cells. 2001 Mutat. Res. pmid:11470494
Khaw AK et al. Inhibition of telomerase activity and human telomerase reverse transcriptase gene expression by histone deacetylase inhibitor in human brain cancer cells. 2007 Mutat. Res. pmid:17669439
Oyer JA et al. Aberrantly silenced promoters retain a persistent memory of the silenced state after long-term reactivation. 2011 Mutat. Res. pmid:21035468
Setlow JK et al. Evidence for gene silencing in Haemophilus influenzae. 2001 Mutat. Res. pmid:11406170
Johnson D and Walmsley R Histone-deacetylase inhibitors produce positive results in the GADD45a-GFP GreenScreen HC assay. 2013 Mutat. Res. pmid:23340162
Sugiyama KI et al. Epigenetic mutagen as histone modulator can be detected by yeast flocculation. 2016 Mutagenesis pmid:27549112
Keuser B et al. Influences of histone deacetylase inhibitors and resveratrol on DNA repair and chromatin compaction. 2013 Mutagenesis pmid:23814181
Gushchina SV et al. [Cellular aspects of regulation of nuclear factor kappaB (NF-kappabeta) transcriptional activity in sensory neurons in vitro]. 2010 Morfologiia pmid:20960709
Kagoshima M et al. How signaling pathways interact with gene transcription. 2003 Jan-Mar Monaldi Arch Chest Dis pmid:14533280
Chen X et al. Design, synthesis and biological evaluation of hydroxamic acid derivatives as potential high density lipoprotein (HDL) receptor CLA-1 up-regulating agents. 2011 Molecules pmid:22048700
Xie M et al. Effects of 5-aza-2'-deoxycytidine and trichostatin A on high glucose- and interleukin-1β-induced secretory mediators from human retinal endothelial cells and retinal pigment epithelial cells. 2014 Mol. Vis. pmid:25352747
Zhou Q et al. Histone deacetylase inhibitors blocked activation and caused senescence of corneal stromal cells. 2008 Mol. Vis. pmid:19122829
Biermann J et al. Histone deacetylase inhibitors sodium butyrate and valproic acid delay spontaneous cell death in purified rat retinal ganglion cells. 2011 Mol. Vis. pmid:21311741
Kitano A et al. Therapeutic potential of trichostatin A to control inflammatory and fibrogenic disorders of the ocular surface. 2010 Mol. Vis. pmid:21203344
Koppaka V et al. Effect of HDAC Inhibitors on Corneal Keratocyte Mechanical Phenotypes in 3-D Collagen Matrices. 2015 Mol. Vis. pmid:25999677
Toscano MG et al. SCL/TAL1-mediated transcriptional network enhances megakaryocytic specification of human embryonic stem cells. 2015 Mol. Ther. pmid:25292191
Handumrongkul C et al. Distinct sets of cellular genes control the expression of transfected, nuclear-localized genes. 2002 Mol. Ther. pmid:11829526
Lim HG et al. Promoter-targeted siRNAs induce gene silencing of simian immunodeficiency virus (SIV) infection in vitro. 2008 Mol. Ther. pmid:18227841
Hofmann A et al. Epigenetic regulation of lentiviral transgene vectors in a large animal model. 2006 Mol. Ther. pmid:16140581
Saayman S et al. An HIV-encoded antisense long noncoding RNA epigenetically regulates viral transcription. 2014 Mol. Ther. pmid:24576854
Nair RR et al. Enhancement of transgene expression by combining glucocorticoids and anti-mitotic agents during transient transfection using DNA-cationic liposomes. 2002 Mol. Ther. pmid:11945073
Qiu GH et al. Recognition and suppression of transfected plasmids by protein ZNF511-PRAP1, a potential molecular barrier to transgene expression. 2011 Mol. Ther. pmid:21540836
Chung YL et al. A therapeutic strategy uses histone deacetylase inhibitors to modulate the expression of genes involved in the pathogenesis of rheumatoid arthritis. 2003 Mol. Ther. pmid:14599803
Liu TC et al. Trichostatin A and oncolytic HSV combination therapy shows enhanced antitumoral and antiangiogenic effects. 2008 Mol. Ther. pmid:18388912
Hartl M et al. Lysine acetylome profiling uncovers novel histone deacetylase substrate proteins in . 2017 Mol. Syst. Biol. pmid:29061669
Xue K et al. Synchronous behaviors of CBP and acetylations of lysine 18 and lysine 23 on histone H3 during porcine oocyte first meiotic division. 2010 Mol. Reprod. Dev. pmid:20575085
Nojima H et al. Increase in DNA methylation downregulates conceptus interferon-tau gene expression. 2004 Mol. Reprod. Dev. pmid:14991730
Yoshizawa Y et al. Impaired active demethylation of the paternal genome in pronuclear-stage rat zygotes produced by in vitro fertilization or intracytoplasmic sperm injection. 2010 Mol. Reprod. Dev. pmid:19743475
Stein P et al. Stage-dependent redistributions of acetylated histones in nuclei of the early preimplantation mouse embryo. 1997 Mol. Reprod. Dev. pmid:9211426
Dehnugara T et al. An in vitro, short-term culture method for mammalian haploid round spermatids amenable for molecular manipulation. 2012 Mol. Reprod. Dev. pmid:21953649
Endo T et al. Changes in histone modifications during in vitro maturation of porcine oocytes. 2005 Mol. Reprod. Dev. pmid:15736133
Dogra SC et al. Evidence that the coactivator CBP/p300 is important for phenobarbital-induced but not basal expression of the CYP2H1 gene. 2003 Mol. Pharmacol. pmid:12488538
Tao W et al. Brainstem brain-derived neurotrophic factor signaling is required for histone deacetylase inhibitor-induced pain relief. 2015 Mol. Pharmacol. pmid:25852071
Choiniere J et al. Pyruvate Dehydrogenase Kinase 4 Deficiency Results in Expedited Cellular Proliferation through E2F1-Mediated Increase of Cyclins. 2017 Mol. Pharmacol. pmid:28003426
Alqinyah M et al. Regulator of G Protein Signaling 10 (Rgs10) Expression Is Transcriptionally Silenced in Activated Microglia by Histone Deacetylase Activity. 2017 Mol. Pharmacol. pmid:28031332
Zhang J et al. Basis for the loss of aryl hydrocarbon receptor gene expression in clones of a mouse hepatoma cell line. 1996 Mol. Pharmacol. pmid:8967965
Lindström TM et al. Histone deacetylase inhibitors exert time-dependent effects on nuclear factor-kappaB but consistently suppress the expression of proinflammatory genes in human myometrial cells. 2008 Mol. Pharmacol. pmid:18375836
Yang L et al. Trichostatin A inhibits transforming growth factor-β-induced reactive oxygen species accumulation and myofibroblast differentiation via enhanced NF-E2-related factor 2-antioxidant response element signaling. 2013 Mol. Pharmacol. pmid:23284002
Shao A et al. Enhancement of Autophagy by Histone Deacetylase Inhibitor Trichostatin A Ameliorates Neuronal Apoptosis After Subarachnoid Hemorrhage in Rats. 2016 Mol. Neurobiol. pmid:25399954
Tan CS et al. Epigenetic Regulation of Cytosolic Phospholipase A2 in SH-SY5Y Human Neuroblastoma Cells. 2016 Mol. Neurobiol. pmid:26162318
Wiesen JL and Tomasi TB Dicer is regulated by cellular stresses and interferons. 2009 Mol. Immunol. pmid:19118902
Rouhi A et al. Plasticity of Ly49g expression is due to epigenetics. 2007 Mol. Immunol. pmid:16750269
Chou SD and Tomasi TB Spatial distribution of histone methylation during MHC class II expression. 2008 Mol. Immunol. pmid:17850872
Danbara M et al. DNA methylation dominates transcriptional silencing of Pax5 in terminally differentiated B cell lines. 2002 Mol. Immunol. pmid:12044782
Magner WJ and Tomasi TB Apoptotic and necrotic cells induced by different agents vary in their expression of MHC and costimulatory genes. 2005 Mol. Immunol. pmid:15829293
Lee SC et al. Activation of terminal B cell differentiation by inhibition of histone deacetylation. 2003 Mol. Immunol. pmid:12695118
Schauber J et al. Histone-deacetylase inhibitors induce the cathelicidin LL-37 in gastrointestinal cells. 2004 Mol. Immunol. pmid:15261456
Nagashima T et al. Histone acetylation and subcellular localization of chromosomal protein BRD4 during mouse oocyte meiosis and mitosis. 2007 Mol. Hum. Reprod. pmid:17267518
Tyson-Capper AJ et al. Characterization of cellular retinoid-binding proteins in human myometrium during pregnancy. 2006 Mol. Hum. Reprod. pmid:16959971
Dokras A et al. Epigenetic regulation of maspin expression in the human placenta. 2006 Mol. Hum. Reprod. pmid:16936308
McGuinness MC et al. Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy. 2001 Sep-Oct Mol. Genet. Metab. pmid:11592822
Zoumpoulidou G et al. Convergence of interferon-gamma and progesterone signaling pathways in human endometrium: role of PIASy (protein inhibitor of activated signal transducer and activator of transcription-y). 2004 Mol. Endocrinol. pmid:15155784
Franco PJ et al. The orphan nuclear receptor TR2 interacts directly with both class I and class II histone deacetylases. 2001 Mol. Endocrinol. pmid:11463856
Ishii S et al. Aberrant dynamics of histone deacetylation at the thyrotropin-releasing hormone gene in resistance to thyroid hormone. 2004 Mol. Endocrinol. pmid:15131262
Jorgensen JS and Nilson JH AR suppresses transcription of the alpha glycoprotein hormone subunit gene through protein-protein interactions with cJun and activation transcription factor 2. 2001 Mol. Endocrinol. pmid:11518798
Maeda Y et al. Repression of hepatocyte nuclear factor 4alpha tumor suppressor p53: involvement of the ligand-binding domain and histone deacetylase activity. 2002 Mol. Endocrinol. pmid:11818510
Chien PY et al. A fusion protein of the estrogen receptor (ER) and nuclear receptor corepressor (NCoR) strongly inhibits estrogen-dependent responses in breast cancer cells. 1999 Mol. Endocrinol. pmid:10598586
Kim MY et al. Acetylation of estrogen receptor alpha by p300 at lysines 266 and 268 enhances the deoxyribonucleic acid binding and transactivation activities of the receptor. 2006 Mol. Endocrinol. pmid:16497729
Clem BF and Clark BJ Association of the mSin3A-histone deacetylase 1/2 corepressor complex with the mouse steroidogenic acute regulatory protein gene. 2006 Mol. Endocrinol. pmid:16109738
McEachern LA and Murphy PR Chromatin-remodeling factors mediate the balance of sense-antisense transcription at the FGF2 locus. 2014 Mol. Endocrinol. pmid:24552587
Jonsen MD et al. The 26-amino acid beta-motif of the Pit-1beta transcription factor is a dominant and independent repressor domain. 2009 Mol. Endocrinol. pmid:19556346
Endo M et al. Novel gender-related regulation of CYP2C12 gene expression in rats. 2005 Mol. Endocrinol. pmid:15661834
Ma L et al. HDAC5-mTORC1 Interaction in Differential Regulation of Ghrelin and Nucleobindin 2 (NUCB2)/Nesfatin-1. 2015 Mol. Endocrinol. pmid:26357899
Ai J et al. HDAC6 regulates androgen receptor hypersensitivity and nuclear localization via modulating Hsp90 acetylation in castration-resistant prostate cancer. 2009 Mol. Endocrinol. pmid:19855091
Newell-Price J et al. The CpG island promoter of the human proopiomelanocortin gene is methylated in nonexpressing normal tissue and tumors and represses expression. 2001 Mol. Endocrinol. pmid:11158338
Sharma M and Sun Z 5'TG3' interacting factor interacts with Sin3A and represses AR-mediated transcription. 2001 Mol. Endocrinol. pmid:11682623
Teyssier C et al. Receptor-interacting protein 140 binds c-Jun and inhibits estradiol-induced activator protein-1 activity by reversing glucocorticoid receptor-interacting protein 1 effect. 2003 Mol. Endocrinol. pmid:12554755
Ezzat S et al. The zinc finger Ikaros transcription factor regulates pituitary growth hormone and prolactin gene expression through distinct effects on chromatin accessibility. 2005 Mol. Endocrinol. pmid:15618287
Chung KS et al. Fission yeast-based screening to identify putative HDAC inhibitors using a telomeric reporter strain. 2008 Mol. Cells pmid:18525239
Koh HS et al. Twist2 regulates CD7 expression and galectin-1-induced apoptosis in mature T-cells. 2009 Mol. Cells pmid:19937140
Lee YJ et al. Mechanism of transcriptional repression by TEL/RUNX1 fusion protein. 2004 Mol. Cells pmid:15179033
Mogal A and Abdulkadir SA Effects of Histone Deacetylase Inhibitor (HDACi); Trichostatin-A (TSA) on the expression of housekeeping genes. 2006 Mol. Cell. Probes pmid:16326072
Fontán-Lozano A et al. Histone deacetylase inhibitors improve learning consolidation in young and in KA-induced-neurodegeneration and SAMP-8-mutant mice. 2008 Mol. Cell. Neurosci. pmid:18638560
Chik CL et al. Histone modifications on the adrenergic induction of type II deiodinase in rat pinealocytes. 2011 Mol. Cell. Endocrinol. pmid:21704117
Vanneste M et al. Hyaluronate synthase-2 overexpression alters estrogen dependence and induces histone deacetylase inhibitor-like effects on ER-driven genes in MCF7 breast tumor cells. 2017 Mol. Cell. Endocrinol. pmid:28137613
Belakavadi M et al. Thyroid hormone suppression of β-amyloid precursor protein gene expression in the brain involves multiple epigenetic regulatory events. 2011 Mol. Cell. Endocrinol. pmid:21458529
Inoue H et al. Analysis of expression and structure of the rat GH-secretagogue/ghrelin receptor (Ghsr) gene: roles of epigenetic modifications in transcriptional regulation. 2011 Mol. Cell. Endocrinol. pmid:21756973
Mehta A et al. HDAC inhibitor prevents LPS mediated inhibition of CYP19A1 expression and 17β-estradiol production in granulosa cells. 2015 Mol. Cell. Endocrinol. pmid:26213324
Lizcano F et al. Cell type-specific roles of histone deacetylase in TR ligand-independent transcriptional repression. 2001 Mol. Cell. Endocrinol. pmid:11165035
Kanasaki H et al. Trichostatin A reduces GnRH mRNA expression with a concomitant increase in retinaldehyde dehydrogenase in GnRH-producing neurons. 2015 Mol. Cell. Endocrinol. pmid:26116234